Supplemental Cash Flow Information (Tables)

9 Months Ended

Sep. 30, 2025

Supplemental Cash Flow Information [Abstract]

Supplemental Cash Flow Information

Expenditures included in accounts payable and accrued expenses were as follows (in thousands):

	As of		As of
	September 30, 2025		September 30, 2024
Costs relating to construction included in accounts payable and accrued expenses	$	16,187	$	19,059

Interest paid, net of interest capitalized was as follows (in thousands):

	Nine months ended
	September 30,
	2025		2024
Interest paid	$	53,088	$	49,370

Non-cash financing activities that occurred during the third quarter of 2025 include the assumption of mortgage debt in the amount of $115.0 million, including net premiums of $3.8 million, related to the acquisition of our center in Kansas City, KS.

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Company:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,992	$	12,778
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,992	$	12,778
End of period:
Cash and cash equivalents	$	13,029	$	11,053
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	50,228	$	11,053

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Operating Partnership:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,700	$	12,572
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,700	$	12,572
End of period:
Cash and cash equivalents	$	12,761	$	10,830
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	49,960	$	10,830

Schedule of Cash and Cash Equivalents

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Company:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,992	$	12,778
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,992	$	12,778
End of period:
Cash and cash equivalents	$	13,029	$	11,053
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	50,228	$	11,053

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Operating Partnership:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,700	$	12,572
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,700	$	12,572
End of period:
Cash and cash equivalents	$	12,761	$	10,830
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	49,960	$	10,830

Schedule of Restricted Cash

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Company:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,992	$	12,778
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,992	$	12,778
End of period:
Cash and cash equivalents	$	13,029	$	11,053
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	50,228	$	11,053

The following table summarizes cash, cash equivalents and restricted cash (in thousands) for the Operating Partnership:

	Nine months ended
	September 30,
	2025		2024
Beginning of period:
Cash and cash equivalents	$	46,700	$	12,572
Restricted cash	—		—
Cash, cash equivalents, and restricted cash	$	46,700	$	12,572
End of period:
Cash and cash equivalents	$	12,761	$	10,830
Restricted cash	37,199		—
Cash, cash equivalents, and restricted cash	$	49,960	$	10,830